Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
1.
Proc Nutr Soc ; 80(3): 344-355, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-33745471

RESUMEN

The objectives are to present an updated synopsis on osteosarcopenic adiposity (OSA) syndrome and evaluate the roles of selected micronutrients in its prevention and management. OSA refers to the concurrent deterioration of bone (osteopenia/osteoporosis), muscle (sarcopenia) and adipose tissue expansion. It portrays the most advanced stage in a continuum of body composition disorders. Although OSA has been widely studied involving the populations of different backgrounds, its prevalence is hard to collate because different methodologies and criteria were used for its diagnosis. Another critical health aspect is the presence of low-grade chronic inflammation (LGCI) which contributes to OSA and vice versa. Nutrition is important in the prevention and management of both OSA and LGCI. Although micronutrients act in numerous metabolic and physiological processes, their roles here are presented in relation to OSA (and its components) and LGCI in general and relevant to the COVID-19 pandemic. These include calcium, magnesium, phosphorus, potassium, sodium and vitamins D and K; their interactions, physiological ratios and synergism/antagonism are discussed as well. In conclusion, calcium, magnesium and vitamin D have a profound impact on OSA and its components, and the latter two also on LGCI. Potassium and vitamin K are vital in bone, muscle functioning and possibly adipose tissue modification. Both, but particularly vitamin D, surfaced as important modulators of immune system with application in COVID-19 infections. While both phosphorus and sodium have important roles in bone, muscle and can impact adiposity, due to their abundance in food, their intake should be curbed to prevent possible damaging effects.


Asunto(s)
Adiposidad , Enfermedades Óseas Metabólicas , Obesidad , Osteoporosis , Sarcopenia , Oligoelementos , Vitaminas , Enfermedades Óseas Metabólicas/dietoterapia , Enfermedades Óseas Metabólicas/prevención & control , COVID-19/epidemiología , Dieta , Humanos , Obesidad/dietoterapia , Obesidad/prevención & control , Osteoporosis/dietoterapia , Osteoporosis/prevención & control , Sarcopenia/dietoterapia , Sarcopenia/prevención & control , Síndrome , Oligoelementos/administración & dosificación , Oligoelementos/metabolismo , Vitaminas/administración & dosificación , Vitaminas/fisiología
2.
Clin Nutr ; 39(12): 3744-3749, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-32307196

RESUMEN

BACKGROUND & AIMS: Nutrition is one of the most important environmental factors affecting the formation of osteopenia. The purpose of this study was to investigate the effects of dietary changes on bone formation and bone resorption markers of postmenopausal women with vertebral osteopenia. METHODS: In this study, 108 women with postmenopausal vertebral osteopenia were included. Patients were observed for a month to identify their regular nutritional status. Before intervention, blood and urine samples were taken from all patients. Then, 2-day food consumption records were taken and the patients were divided into 4 groups. Different types of diets (opposite of their regular diets) were prepared for these groups (1: control, 2: reduced-carbohydrate, 3: reduced-protein, 4: reduced-sodium) and followed for 3 months. At the end of follow-ups, blood and urine samples were taken again and changes in osteocalcin (OC) and N-terminal telopeptide (NTX) levels were examined. RESULTS: According to biochemical analysis, there was a significant decrease (p < 0,001) in OC levels in reduced protein group and an increase (p > 0,05) in reduced carbohydrate group. When NTX levels were assessed, a significant decrease (p < 0.001) in the reduced carbohydrate group and a significant increase in the reduced protein group (p < 0.05) were found. CONCLUSION: Our findings show that reduced carbohydrate diet protected whereas, reduced protein diet negatively affected bone health. Osteopenic individuals were thought to be able to improve bone health and their quality of life by early dietary intervention.


Asunto(s)
Enfermedades Óseas Metabólicas/dietoterapia , Dieta/métodos , Posmenopausia/sangre , Posmenopausia/orina , Absorciometría de Fotón , Biomarcadores/sangre , Biomarcadores/orina , Densidad Ósea , Enfermedades Óseas Metabólicas/sangre , Enfermedades Óseas Metabólicas/orina , Colágeno Tipo I/sangre , Colágeno Tipo I/orina , Registros de Dieta , Dieta Baja en Carbohidratos , Dieta con Restricción de Proteínas , Dieta Hiposódica , Femenino , Humanos , Persona de Mediana Edad , Estado Nutricional , Osteocalcina/sangre , Osteocalcina/orina , Péptidos/sangre , Péptidos/orina , Resultado del Tratamiento
3.
Nutrients ; 11(6)2019 Jun 23.
Artículo en Inglés | MEDLINE | ID: mdl-31234587

RESUMEN

The diurnal rhythm of bone remodeling suggests nocturnal dietary intervention to be most effective. This study investigated the effect of bedtime ingestion of a calcium-fortified, milk-derived protein matrix (MBPM) or maltodextrin (CON) on acute (0-4 h) blood and 24-h urinary change in biomarkers of bone remodeling in postmenopausal women with osteopenia. In CON, participants received 804 ± 52 mg calcium, 8.2 ± 3.2 µg vitamin D and 1.3 ± 0.2 g/kg BM protein per day. MBPM increased calcium intake to 1679 ± 196 mg, vitamin D to 9.2 ± 3.1 µg and protein to 1.6 ± 0.2 g/kg BM. Serum C-terminal cross-linked telopeptide of type I collagen (CTX) and procollagen type 1 amino-terminal propeptide (P1NP), and urinary N-telopeptide cross-links of type I collagen (NTX), pyridinoline (PYD) and deoxypyridinoline (DPD) was measured. Analyzed by AUC and compared to CON, a -32% lower CTX (p = 0.011, d = 0.83) and 24% (p = 0.52, d = 0.2) increase in P1NP was observed for MBPM. Mean total 24 h NTX excreted in MBPM was -10% (p = 0.035) lower than CON. Urinary PYD and DPD were unaffected by treatment. This study demonstrates the acute effects of bedtime ingestion of a calcium-fortified, milk-based protein matrix on bone remodeling.


Asunto(s)
Enfermedades Óseas Metabólicas/dietoterapia , Remodelación Ósea , Calcio de la Dieta/administración & dosificación , Ritmo Circadiano , Suplementos Dietéticos , Alimentos Fortificados , Proteínas de la Leche/administración & dosificación , Posmenopausia/sangre , Anciano , Biomarcadores/sangre , Enfermedades Óseas Metabólicas/sangre , Enfermedades Óseas Metabólicas/diagnóstico , Enfermedades Óseas Metabólicas/fisiopatología , Calcio de la Dieta/efectos adversos , Colágeno Tipo I/sangre , Suplementos Dietéticos/efectos adversos , Femenino , Alimentos Fortificados/efectos adversos , Humanos , Irlanda , Persona de Mediana Edad , Proteínas de la Leche/efectos adversos , Hormona Paratiroidea/sangre , Fragmentos de Péptidos/sangre , Péptidos/sangre , Procolágeno/sangre , Factores de Tiempo , Resultado del Tratamiento , Vitamina D/administración & dosificación
4.
J Food Sci ; 84(2): 349-357, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30726579

RESUMEN

Osteopenia is a preclinical phase of osteoporosis, it occurs naturally with aging and increases the risk of bone fractures in elderly males. Previous studies have revealed the beneficial effects of soybean on preventing bone loss due to its isoflavone contents. Fermentation alters the soybean isoflavone contents, that is, isoflavone glucosides is hydrolyzed into aglycones. However, it is not clear how these alterations influences the preventive effect of soybean on bone loss. In this study, we fed senescence-accelerated mouse prone 6 (SAMP6), a model of senile osteopenia, with an equal dosage of nonfermented soybean (NS) or fermented soybean, Doenjang (DJ) for 18 weeks. Mice supplemented with DJ showed 1.13-fold higher bone densities and 1.06-fold longer relative bone lengths than those of osteopenic SAMP6 mice old control (OC), while NS-supplemented mice showed no significant improvement. Supplementation with DJ effectively prevented bone loss in the osteopenia model by the improvement of bone formation and reduction of osteoclastogenesis. In addition, we discovered that DJ increased osteogenesis in SAMP6 mice via BMP2-Smad-Runx2 signaling. These results suggest that the fermentation process could enhance bone loss prevention by soybean and dietary supplementation with fermented soybeans may be beneficial for bone health. PRACTICAL APPLICATION: Soybean fermentation improved the preventive effects of soybean on bone loss. Therefore, the consumption of fermented soybean, Doenjang, is a potential alternative for aging-related bone loss therapy.


Asunto(s)
Enfermedades Óseas Metabólicas/dietoterapia , Glycine max/metabolismo , Osteoporosis/tratamiento farmacológico , Animales , Bacillus subtilis/metabolismo , Enfermedades Óseas Metabólicas/metabolismo , Modelos Animales de Enfermedad , Femenino , Fermentación , Humanos , Isoflavonas/metabolismo , Masculino , Ratones , Osteoporosis/metabolismo , Glycine max/química , Glycine max/microbiología
5.
Praxis (Bern 1994) ; 107(15): 817-824, 2018 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-30043704

RESUMEN

The Influence of Protein on the Prevention of Fragility Fractures Among Senior Adults Abstract. The aim of this review article is to discuss protein intake in senior adults at risk for fragility fractures as a modifiable factor for fracture prevention. Proteins are building blocks of the bone matrix and the muscles. This dual function fits in with the concept of prevention of fragility fractures in senior adults aimed at reducing both bone loss and falls. In older adults, a protein-rich diet could be another simple and effective way to promote bone and muscle health, in addition to the established recommendations for adequate vitamin D and calcium intake.


Asunto(s)
Enfermedades Óseas Metabólicas/prevención & control , Dieta Rica en Proteínas , Anciano Frágil , Fracturas Osteoporóticas/prevención & control , Deficiencia de Proteína/prevención & control , Accidentes por Caídas/prevención & control , Anciano , Anciano de 80 o más Años , Enfermedades Óseas Metabólicas/dietoterapia , Calcio de la Dieta/administración & dosificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Fracturas Osteoporóticas/dietoterapia , Deficiencia de Proteína/dietoterapia , Factores de Riesgo , Sarcopenia/dietoterapia , Sarcopenia/prevención & control , Vitamina D/administración & dosificación
7.
Curr Osteoporos Rep ; 15(5): 459-472, 2017 10.
Artículo en Inglés | MEDLINE | ID: mdl-28831686

RESUMEN

PURPOSE OF REVIEW: The review aims to summarize our current knowledge surrounding treatment strategies aimed at recovery of bone mass in energy-deficient women suffering from the Female Athlete Triad. RECENT FINDINGS: The independent and interactive contributions of energy status versus estrogen status on bone density, geometry, and strength have recently been reported, highlighting the importance of addressing both energy and estrogen in treatment strategies for bone health. This is supported by reports that have identified energy-related features (low body weight and BMI) and estrogen-related features (late age of menarche, oligo/amenorrhea) to be significant risk factors for low bone mineral density and bone stress injury in female athletes and exercising women. Nutritional therapy is the recommended first line of treatment to recover bone mass in energy-deficient female athletes and exercising women. If nutritional therapy fails after 12 months or if fractures or significant worsening in BMD occurs, pharmacological therapy may be considered in the form of transdermal estradiol with cyclic oral progestin (not COC).


Asunto(s)
Densidad Ósea , Ingestión de Energía , Ejercicio Físico , Síndrome de la Tríada de la Atleta Femenina/dietoterapia , Desnutrición/dietoterapia , Terapia Nutricional/métodos , Osteoporosis/dietoterapia , Administración Cutánea , Administración Oral , Amenorrea , Enfermedades Óseas Metabólicas/dietoterapia , Enfermedades Óseas Metabólicas/tratamiento farmacológico , Enfermedades Óseas Metabólicas/etiología , Metabolismo Energético , Estradiol/uso terapéutico , Estrógenos/uso terapéutico , Femenino , Síndrome de la Tríada de la Atleta Femenina/complicaciones , Síndrome de la Tríada de la Atleta Femenina/tratamiento farmacológico , Humanos , Desnutrición/complicaciones , Osteoporosis/tratamiento farmacológico , Osteoporosis/etiología , Fracturas Osteoporóticas/prevención & control , Progestinas/uso terapéutico , Delgadez
8.
Eur J Clin Nutr ; 71(9): 1101-1107, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28561037

RESUMEN

BACKGROUND/OBJECTIVES: Evidence supporting the possible effect of dietary factors on adult bone health has emerged in recent decades. The purpose of this study was to ascertain the influence of different dietary patterns on bone mineral density (BMD) among Korean male youth. SUBJECTS/METHODS: Data were extracted from the Korean National Health and Nutrition Examination Survey (KNHANES) during 2008-2011. The subjects included 1351 male aged 10-25 years. We defined 'low BMD group' as subjects with a BMD Z-score of -2.0 or less. Dietary patterns were derived from 20 food groups via factor analysis. RESULTS: Three dietary patterns-meat and vegetable, white rice and kimchi, milk-cereal and whole grain-were derived. The 'milk-cereal and whole-grain' dietary pattern score showed positive association with energy, protein, fat, calcium, phosphorus, potassium, riboflavin and vitamin C intakes. Participants in the top tertile of the milk-cereal and whole-grain pattern were less likely to have low BMD, compared with subjects in the bottom tertile (odds ratio=0.36, 95% confidence interval=0.16-0.81, P=0.018). CONCLUSIONS: Our findings suggest that the milk-cereal and whole-grain dietary pattern may have a benign influence on bone health in the Korean male youth.


Asunto(s)
Densidad Ósea , Enfermedades Óseas Metabólicas/epidemiología , Grano Comestible , Leche , Granos Enteros , Adolescente , Servicios de Salud del Adolescente , Adulto , Animales , Enfermedades Óseas Metabólicas/dietoterapia , Enfermedades Óseas Metabólicas/prevención & control , Calcio de la Dieta/administración & dosificación , Niño , Carbohidratos de la Dieta/administración & dosificación , Conducta Alimentaria , Humanos , Masculino , Encuestas Nutricionales , República de Corea/epidemiología , Factores de Riesgo , Adulto Joven
9.
J Vet Med Sci ; 78(4): 563-71, 2016 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-26725871

RESUMEN

The aim of the study was to investigate the effect of 2-oxoglutaric acid (2-Ox) supplementation (a precursor of glutamine and hydroxyproline, the most abundant amino acid of collagen) on cartilage and bone in pigs after fundectomy. Pigs at the age of forty days were subjected to fundectomy and divided into two groups depending on 2-Ox supplementation (at the daily dosage of 0.4 g/kg of body weight). Other pigs were sham operated. Pigs were euthanized at the age of eight months. An analysis of the morphometry of trabeculae, growth plate and articular cartilage in fundectomy-induced osteopenic bone was performed. Moreover, the levels of expression of osteocalcin, osteopontin and osteoprotegerin in trabecular bone and osteocalcin in articular cartilage were evaluated. Articular cartilage was thinnest in fundectomized pigs and thickest in 2-Ox-supplemented animals after fundectomy. Moreover, 2-Ox supplementation after fundectomy enhanced the total thickness of the growth plate and trabeculae in fundectomized pigs. The most evident signal for osteocalcin and osteoprotegerin in trabecular bone was in sham-operated and 2-Ox-supplemented pigs; a low reaction was observed in the fundectomized group. Additionally, as a long-term postoperative consequence, a change was observed in the expression of osteocalcin in articular cartilage. It seems that 2-Ox is suitable for use in preventing the negative effects of fundectomy on cancellous bone and cartilage.


Asunto(s)
Enfermedades Óseas Metabólicas/dietoterapia , Hueso Esponjoso , Cartílago Articular , Placa de Crecimiento , Ácidos Cetoglutáricos/uso terapéutico , Animales , Peso Corporal , Enfermedades Óseas Metabólicas/etiología , Enfermedades Óseas Metabólicas/patología , Hueso Esponjoso/patología , Cartílago Articular/metabolismo , Cartílago Articular/patología , Colágeno/metabolismo , Fundus Gástrico/cirugía , Placa de Crecimiento/patología , Masculino , Osteocalcina/biosíntesis , Proteoglicanos/metabolismo , Porcinos
10.
Calcif Tissue Int ; 98(1): 94-103, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26511476

RESUMEN

Increasing calcium (Ca) intake is important for female athletes with a risk of weak bone caused by inadequate food intake. The aim of the present study was to examine the preventive effect of Ca supplementation on low bone strength in young female athletes with inadequate food intake, using the rats as an experimental model. Seven-week-old female Sprague-Dawley rats were divided into four groups: the sedentary and ad libitum feeding group (SED), voluntary running exercise and ad libitum feeding group (EX), voluntary running exercise and 30% food restriction group (EX-FR), and a voluntary running exercise, 30% food-restricted and high-Ca diet group (EX-FR+Ca). To Ca supplementation, we used 1.2% Ca diet as "high-Ca diet" that contains two-fold Ca of normal Ca diet. The experiment lasted for 12 weeks. As a result, the energy availability, internal organ weight, bone strength, bone mineral density, and Ca absorption in the EX-FR group were significantly lower than those in the EX group. The bone strength and Ca absorption in the EX-FR+Ca group were significantly higher than those in the EX-FR group. However, the bone strength in the EX-FR+Ca group did not reach that in the EX group. These results suggested that Ca supplementation had a positive effect on bone strength, but the effect was not sufficient to prevent lower bone strength caused by food restriction in young female athletes.


Asunto(s)
Desarrollo Óseo/efectos de los fármacos , Enfermedades Óseas Metabólicas/prevención & control , Huesos/efectos de los fármacos , Calcio de la Dieta/farmacología , Restricción Calórica/efectos adversos , Privación de Alimentos/fisiología , Condicionamiento Físico Animal/efectos adversos , Animales , Densidad Ósea/efectos de los fármacos , Enfermedades Óseas Metabólicas/dietoterapia , Remodelación Ósea/efectos de los fármacos , Huesos/anatomía & histología , Huesos/diagnóstico por imagen , Suplementos Dietéticos , Femenino , Radiografía , Ratas , Ratas Sprague-Dawley , Carrera/fisiología
12.
Br J Nutr ; 106(6): 923-30, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21736808

RESUMEN

Aside from existing drug therapies, certain lifestyle and nutritional factors are known to reduce the risk of osteoporosis. Among the nutritional factors, dried plum or prunes (Prunus domestica L.) is the most effective fruit in both preventing and reversing bone loss. The objective of the present study was to examine the extent to which dried plum reverses bone loss in osteopenic postmenopausal women. We recruited 236 women, 1-10 years postmenopausal, not on hormone replacement therapy or any other prescribed medication known to influence bone metabolism. Qualified participants (n 160) were randomly assigned to one of the two treatment groups: dried plum (100 g/d) or dried apple (comparative control). Participants received 500 mg Ca plus 400 IU (10 µg) vitamin D daily. Bone mineral density (BMD) of lumbar spine, forearm, hip and whole body was assessed at baseline and at the end of the study using dual-energy X-ray absorptiometry. Blood samples were collected at baseline, 3, 6 and 12 months to assess bone biomarkers. Physical activity recall and 1-week FFQ were obtained at baseline, 3, 6 and 12 months to examine physical activity and dietary confounders as potential covariates. Dried plum significantly increased BMD of ulna and spine in comparison with dried apple. In comparison with corresponding baseline values, only dried plum significantly decreased serum levels of bone turnover markers including bone-specific alkaline phosphatase and tartrate-resistant acid phosphatase-5b. The findings of the present study confirmed the ability of dried plum in improving BMD in postmenopausal women in part due to suppressing the rate of bone turnover.


Asunto(s)
Enfermedades Óseas Metabólicas/dietoterapia , Huesos/efectos de los fármacos , Calcio/metabolismo , Malus/metabolismo , Osteoporosis Posmenopáusica/prevención & control , Prunus/metabolismo , Fosfatasa Ácida/metabolismo , Anciano , Fosfatasa Alcalina/metabolismo , Antropometría/métodos , Biomarcadores/metabolismo , Densidad Ósea , Dieta , Ejercicio Físico , Femenino , Humanos , Isoenzimas/metabolismo , Persona de Mediana Edad , Posmenopausia , Columna Vertebral/efectos de los fármacos , Fosfatasa Ácida Tartratorresistente , Cúbito/efectos de los fármacos
13.
Metabolism ; 60(10): 1425-32, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21550090

RESUMEN

Daidzein is metabolized to equol in the gastrointestinal tract by gut microflora. Equol has greater estrogenic activity than genistein and daidzein, with its production shown to be promoted by dietary fiber. It is known that resistant starch (RS) is not absorbed in the proximal intestine and acts as dietary fiber in the colon. In this study, we investigated the combined effects of daidzein and RS intake on equol production, bone mineral density, and intestinal microflora in ovariectomized (OVX) mice. Female mice of the ddY strain, aged 8 weeks, were either sham operated (n = 6) or OVX. The OVX mice were randomly divided into 5 groups: OVX control (n = 6), OVX fed 0.1% daidzein-supplemented diet (OVX + Dz, n = 8), OVX fed 0.1% daidzein- and 12% RS-supplemented diet (OVX + Dz + RS, n = 8), OVX fed 12% RS-supplemented diet (OVX + RS, n = 8), and OVX who received daily subcutaneous administration of 17 ß-estradiol (n = 6). After 6 weeks, urinary equol concentration was significantly higher in the OVX + Dz + RS group than in the OVX + Dz group. The bone mineral density of the whole tibia was higher in the OVX + Dz +RS group compared with the OVX + Dz group. The occupation ratios of Bifidobacterium spp in the cecal microflora in groups fed RS were significantly higher than those in the other groups. The present study demonstrated that RS may increase the bioavailability of daidzein.


Asunto(s)
Enfermedades Óseas Metabólicas/tratamiento farmacológico , Equol/metabolismo , Isoflavonas/uso terapéutico , Ovariectomía , Almidón/farmacología , Tibia/efectos de los fármacos , Animales , Densidad Ósea/efectos de los fármacos , Conservadores de la Densidad Ósea/uso terapéutico , Enfermedades Óseas Metabólicas/dietoterapia , Enfermedades Óseas Metabólicas/metabolismo , Ciego/efectos de los fármacos , Ciego/microbiología , Terapia Combinada , Sinergismo Farmacológico , Femenino , Isoflavonas/sangre , Isoflavonas/orina , Ratones , Almidón/metabolismo , Tibia/metabolismo , Regulación hacia Arriba/efectos de los fármacos
14.
Nefrologia ; 31 Suppl 1: 3-32, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21468161
15.
Br J Nutr ; 105(2): 282-6, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20854699

RESUMEN

Ageing women may choose to drink soya milk to reduce menopausal symptoms. As fermentation enriches soya milk with isoflavone aglycones, its beneficial qualities may improve. To reduce osteoporotic risk, however, soya milk must be Ca enriched, and it is not known how fermentation affects Ca bioavailability. A randomised crossover pilot study was undertaken to compare the Ca absorption of fortified soya milk with that of fermented and fortified soya milk in twelve Australian osteopenic post-menopausal women. The fortified soya milk was inoculated with Lactobacillus acidophilus American Type Culture Collection (ATCC) 4962 and fermented for 24 h at 37°C. Ca absorption from soya milk samples was measured using a single isotope radiocalcium method. Participants had a mean age of 54·8 (sd 12·3) years, with mean BMI of 26·5 (sd 5·5) kg/m2 and subnormal to normal serum 25-hydroxyvitamin D (mean 62·5 (sd 19·1) nmol/l). Participants consumed 185 kBq of 45Ca in 44 mg of Ca carrier. The mean fractional Ca absorption (α) from soya milk and fermented soya milk was 0·64 (sd 0·23) and 0·71 (sd 0·29), respectively, a difference not of statistical significance (P = 0·122). Although fermentation of soya milk may provide other health benefits, fermentation had little effect on acute Ca absorption.


Asunto(s)
Enfermedades Óseas Metabólicas/dietoterapia , Calcio de la Dieta/administración & dosificación , Calcio de la Dieta/farmacocinética , Absorción Intestinal , Leche de Soja/administración & dosificación , Anciano , Disponibilidad Biológica , Enfermedades Óseas Metabólicas/fisiopatología , Estudios Cruzados , Femenino , Fermentación , Alimentos Fortificados , Humanos , Lactobacillus acidophilus , Persona de Mediana Edad , Proyectos Piloto , Posmenopausia , Probióticos , Leche de Soja/química
17.
Vopr Pitan ; 78(4): 21-9, 2009.
Artículo en Ruso | MEDLINE | ID: mdl-19999815

RESUMEN

It has been shown that inclusion of the specialized product containing 50% from recommended daily consumption of calcium, 20% of protein, 17-60% of 11 mineral substances and 11 vitamins in the diet of patients suffering from diseases of gastroenteric tract and osteopenia within 6 months lead to increasing of bone mineral density while it has not liquidated the existing vitamin B2 and vitamin D deficiency. The data obtained confirm the expediency of the development of specialized products of the set chemical composition intended for a concrete category of patients, and their inclusion in the diet.


Asunto(s)
Enfermedades Óseas Metabólicas/dietoterapia , Carbohidratos de la Dieta/administración & dosificación , Proteínas en la Dieta/administración & dosificación , Enfermedades Gastrointestinales/dietoterapia , Vitaminas/administración & dosificación , Anciano , Densidad Ósea/efectos de los fármacos , Enfermedades Óseas Metabólicas/complicaciones , Enfermedades Óseas Metabólicas/metabolismo , Femenino , Enfermedades Gastrointestinales/complicaciones , Enfermedades Gastrointestinales/metabolismo , Humanos , Persona de Mediana Edad , Deficiencia de Vitamina D/complicaciones , Deficiencia de Vitamina D/dietoterapia , Deficiencia de Vitamina D/metabolismo
18.
BMC Musculoskelet Disord ; 10: 110, 2009 Sep 04.
Artículo en Inglés | MEDLINE | ID: mdl-19732445

RESUMEN

BACKGROUND: Osteoporosis is a major health problem in postmenopausal women. Evidence suggests the importance of oxidative stress in bone metabolism and bone loss. Tea consumption may be beneficial to osteoporosis due to its antioxidant capability. However, lack of objective data characterizing tea consumption has hindered the precise evaluation of the association between tea ingestion and bone mineral density in previous questionnaire-based epidemiological studies. On the other hand, although published studies suggest that Tai Chi (TC) exercise can benefit bone health and may reduce oxidative stress, all studies were conducted using a relatively healthy older population, instead of a high-risk one such as osteopenic postmenopausal women. Therefore, this study was designed to test an intervention including green tea polyphenol (GTP) and TC exercise for feasibility, and to quantitatively assess their individual and interactive effects on postmenopausal women with osteopenia. METHODS/DESIGN: One hundred and forty postmenopausal women with osteopenia (defined as bone mineral density T-score at the spine and/or hip between 1 to 2.5 SD below the reference database) were randomly assigned to 4 treatment arms: (1) placebo group receiving 500 mg medicinal starch daily, (2) GTP group receiving 500 mg of GTP per day, (3) placebo+TC group receiving both placebo treatment and TC training (60-minute group exercise, 3 times per week), and (4) GTP+TC group receiving both GTP and TC training for 24 weeks. The outcome measures were bone formation biomarker (serum bone alkaline phosphatase), bone resorption biomarker (serum tartrate resistant acid phosphatase), and oxidative DNA damage biomarker (urinary 8-hydroxy-2'-deoxyguanosine). All outcome measures were determined at baseline, 4, 12, and 24 weeks. Urinary and serum GTP concentrations were also determined at baseline, 4, 12, and 24 weeks for bioavailability. Liver function was monitored monthly for safety. A model of repeated measurements with random effect error terms was applied. Traditional procedures such as ANCOVA, chi-squared analysis, and regression were used for comparisons. DISCUSSION: We present the rationale, design, and methodology of a placebo-controlled randomized trial to investigate a new complementary and alternative medicine strategy featuring a dietary supplement and a mind-body exercise for alleviating bone loss in osteopenic postmenopausal women.


Asunto(s)
Flavonoides/uso terapéutico , Osteogénesis , Fenoles/uso terapéutico , Ensayos Clínicos Controlados Aleatorios como Asunto/métodos , Taichi Chuan , , Anciano , Densidad Ósea/efectos de los fármacos , Densidad Ósea/fisiología , Enfermedades Óseas Metabólicas/dietoterapia , Enfermedades Óseas Metabólicas/prevención & control , Suplementos Dietéticos , Terapia por Ejercicio/métodos , Femenino , Flavonoides/farmacología , Humanos , Persona de Mediana Edad , Osteogénesis/efectos de los fármacos , Osteogénesis/fisiología , Osteoporosis Posmenopáusica/dietoterapia , Osteoporosis Posmenopáusica/prevención & control , Fenoles/farmacología , Polifenoles
19.
Arch. latinoam. nutr ; 59(1): 14-21, mar. 2009. graf, tab
Artículo en Inglés | LILACS | ID: lil-588686

RESUMEN

Adolescents’ eating habits are determined by social, psychological, economic, political, and educational influences. They tend to prefer foods with inadequate nutritional value and high fat and carbohydrate content which leads to excessive weight gain and for many, calcium intake is restricted. According to some authors, low calcium intake is linked to increased adiposity. The objective was to evaluate adolescent calcium intake and investigate a possible relationship between calcium intake and nutritional state. As part of their first consultation at Botucatu Adolescent Outpatient Clinic -UNESP, 107 adolescents were nutritionally classified by BMI, according to age, gender, and bands proposed by CDC and AAP. Diet was evaluated by a 3 day 24h food recall, adopting 1300mg/day calcium intake as recommended by Dietary Reference Intakes. Median calcium intake for the whole sample was 546.6mg/day, with 91.30 percent female and 86.84 percent male presenting lower than adequate daily recommended ingestion levels (DRI). There was significant difference between calcium densities (Ca mg/1000kcal) in eutrophic and overweight/obesity in males. Male adolescents showed an inverse relationship between calcium intake and adiposity (r= -0.488 and p=0.0173), which corroborates the hypothesis that low calcium intake is linked to fatty tissue gain. Only 8.70 percent of female and 13.16 percent of male adolescents reached their daily recommended calcium intake levels. It must therefore be stressed that nutritional education is an important protection factor for children and adolescents in later life.


Los hábitos alimentarios se desarrollan dependiendo de los determinantes sociales, psicológicos, económicos, políticos y educacionales y sus preferencias recaen sobre alimentos con inadecuado valor nutricional, elevado contenido de grasa y carbohidratos que conducen a un aumento excesivo de peso. De acuerdo con algunos autores la baja ingestión de calcio se asocia al incremento de la adiposidad. Los objetivos fueron evaluar la ingestión de calcio por adolescentes e investigar una posible relación con el estado nutricional. En su primera consulta en el Ambulatorio de Medicina del Adolescente-Botucatu-UNESP, 107 adolescentes se clasificaron nutricionalmente por el IMC, de acuerdo con la edad y sexo y puntos de corte propuestos por el CDC y AAP. La evaluación dietética fue realizada por el método de recordatorio de 24 hrs. en 3 días diferentes y se adoptó la recomendación de Dietary Reference Intakes (DRI), de 1.300 mg de Ca/día. La ingestión mediana de calcio para la muestra total fue de 546,6 mg/día. Un 91,3 por ciento de las adolescentes y un 86,8 por ciento de los jóvenes presentaron un consumo inferior a los valores de DRI. Al comparar la densidad de calcio (Ca mg/1.000 kcal) entre los grupos eutróficos y sobrepeso/obeso del sexo masculino, se constató una diferencia significativa. En los adolescentes masculinos se evidenció una relación inversa enttre consumo de calcio y adiposidad (r = -0,488 y p = 0,0173), lo cual confirma la hipótesis de que la baja ingestión de calcio se asocia al aumento de tejido graso. Solamente el 8,7 por ciento de las adolescentes mujeres alcanzaron las recomendaciones diarias de DRI y de los adolescente masculinos, el 13,16 por ciento.


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Calcio de la Dieta/efectos adversos , Enfermedades Óseas Metabólicas/dietoterapia , Obesidad , Fenómenos Fisiológicos Nutricionales de los Adolescentes
20.
Gastroenterol Clin Biol ; 33(2): 109-14, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19201117

RESUMEN

AIM: The aim of the study was to assess the evolution of bone mineral density (BMD) in children with celiac disease and to evaluate the effect of a gluten-free diet (GFD). METHODS: Altogether, 44 children (31 girls and 13 boys) were followed-up. BMD was measured by dual-energy X-ray absorptiometry of the lumbar spine (Hologic QDR 4500). Results are expressed as absolute values for BMD, and as Z scores for chronological age (BMD/CA) and bone age (BMD/BA). Patients were divided into two groups according to whether they followed a diet without (n=34) or with (n=10) gluten for at least 1 year. All patients were clinically free of symptoms at the end of the follow-up. RESULTS: At inclusion, 26 patients (59%) were delayed in bone age, 17 children (38%) had a BMD/CA< or =1 S.D. and six (13.6%) had a BMD/CA< or =2 S.D., whereas nine children (20%) had a BMD/BA< or =1 S.D. and three (6.8%) had a BMD/BA< or =2 S.D. During the follow-up, the BMD increase was greater in the GFD group, as determined by the BMD/CA/year (+0.05+/-0.3 vs -0.34+/-0.4 S.D.; P<0.01) and BMD/BA/year (-0.02+/-0.4 vs -0.4+/-0.6 S.D.; P<0.05). The gain in BMD/BA was smaller in the GFD group because of their need to catch up in bone maturation. CONCLUSION: Celiac children not following a GFD show delays in both bone maturation and mineralization. This prospective study confirms the importance of maintaining a GFD in children with celiac disease until the end of skeletal mineralization even in asymptomatic patients following a non-restricted diet.


Asunto(s)
Densidad Ósea , Enfermedad Celíaca/dietoterapia , Dieta Sin Gluten , Absorciometría de Fotón , Adolescente , Determinación de la Edad por el Esqueleto , Desarrollo Óseo , Enfermedades Óseas Metabólicas/dietoterapia , Enfermedades Óseas Metabólicas/etiología , Enfermedad Celíaca/complicaciones , Enfermedad Celíaca/diagnóstico , Niño , Preescolar , Femenino , Humanos , Lactante , Estudios Longitudinales , Vértebras Lumbares , Masculino , Estudios Prospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...